Carter Pieper
Physician Assistant · Chattanooga, TNNPI 1124510193
Payments from drug & device makers
Across 388 payments — averaging $16.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Lilly USA, LLC$762
- Bayer$453
- AstraZeneca$384
- Abbott$333
- Astellas Pharma US Inc$330
- plus $3K from 32 others
What the payments were for
- Food & beverage$6,487100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 104 | $1,690 |
| Lilly USA, LLC | 55 | $762 |
| Bayer | 21 | $453 |
| AstraZeneca | 22 | $384 |
| Abbott | 16 | $333 |
| Astellas Pharma US Inc | 11 | $330 |
| Amgen | 23 | $293 |
| Pfizer | 15 | $234 |
| Boehringer Ingelheim | 13 | $227 |
| Amarin Pharma, Inc. | 13 | $224 |
| Sanofi-aventis U.S. LLC | 12 | $180 |
| Johnson & Johnson | 11 | $152 |
| Esperion Therapeutics, Inc. | 8 | $133 |
| AbbVie | 8 | $129 |
| Novartis | 8 | $122 |
| Merck | 7 | $101 |
| Inspire Medical Systems, Inc. | 3 | $94 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $93 |
| Seqirus USA Inc | 5 | $81 |
| Boston Scientific | 3 | $62 |
| Sunovion Pharmaceuticals Inc. | 3 | $41 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| Mannkind Corporation | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Nevro Corp. | 1 | $22 |
| VBI Vaccine (delaware) Inc. | 1 | $20 |
| Grifols USA, LLC | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Chiesi USA, Inc. | 1 | $13 |
| Almatica Pharma LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,487 in reported general payments places this provider in the 90th percentile of 2,404 physician assistant providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 68 | $63,373 |
| OzempicSemaglutide | 30 | $43,173 |
| EliquisApixaban | 42 | $40,704 |
| RybelsusSemaglutide | 26 | $35,936 |
| XareltoRivaroxaban | 29 | $23,116 |
| JanuviaSitagliptin Phosphate | 16 | $15,487 |
| FarxigaDapagliflozin Propanediol | 13 | $13,128 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $8,249 |
| Rosuvastatin Calcium | 227 | $3,323 |
| SynthroidLevothyroxine Sodium | 25 | $2,560 |
| Atorvastatin Calcium | 156 | $2,246 |
| Omeprazole | 103 | $1,686 |
| Losartan Potassium | 120 | $1,666 |
| Pravastatin Sodium | 98 | $1,494 |
| Metformin Hcl ErMetformin Hcl | 136 | $1,428 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,690 | $79,10956 claims |
| Boehringer IngelheimJardiance | $227 | $63,37368 claims |
| PfizerEliquis | $234 | $40,70442 claims |
| MerckJanuvia, Janumet | $101 | $23,73627 claims |
| Johnson & JohnsonXarelto | $152 | $23,11629 claims |
| AstraZenecaFarxiga | $384 | $13,12813 claims |
| AbbVieSynthroid | $129 | $2,56025 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,404 physician assistant providers in Tennessee.
Other physician assistant in Chattanooga
- Gena ThompsonChattanooga$13K
- Danielle CiabattoneChattanooga$12K
- Lindsey NixKnoxville$576K
- Anna KerseySavannah$399K
- Jason HenryNashville$329K
- Brie ChandlerNashville$317K
- Loree EasleyBartlett$209K
- Katherine RunyanKnoxville$156K
- John KramerNashville$125K
- Robert LaughertyAlcoa$122K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.